Aldeyra Therapeutics, INC. (ALDX) SEC Filings — 2024
22 SEC filings for Aldeyra Therapeutics, INC. (ALDX) in 2024.
Filings
- Aldeyra Therapeutics Files 8-K: Material Agreement — 8-K · Nov 18, 2024
- Aldeyra Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Aldeyra Therapeutics Files Q3 2024 10-Q — 10-Q · Nov 7, 2024
- Aldeyra Therapeutics Files 8-K — 8-K · Oct 3, 2024
- Aldeyra Therapeutics Enters Material Agreement, Incurs Financial Obligation — 8-K · Oct 2, 2024
- Aldeyra Therapeutics Announces Board and Compensation Changes — 8-K · Sep 3, 2024
- Aldeyra Therapeutics Files 8-K — 8-K · Aug 8, 2024
- Aldeyra Therapeutics Enters Material Definitive Agreement — 8-K · Aug 1, 2024
- Aldeyra Therapeutics Files Q2 2024 10-Q — 10-Q · Aug 1, 2024
- Aldeyra Sells Subsidiary for $10M — 8-K · Jun 20, 2024
- Aldeyra Therapeutics Files 8-K — 8-K · Jun 13, 2024
- Aldeyra Therapeutics Holds 2024 Annual Meeting — 8-K · Jun 7, 2024
- Aldeyra Therapeutics Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 2, 2024
- Amgen to Acquire Aldeyra Therapeutics for $6.1B — 8-K · Apr 25, 2024
- Aldeyra Therapeutics Announces 2024 Annual Meeting of Stockholders — DEF 14A · Apr 22, 2024
- Aldeyra Sells Subsidiary for $50M — 8-K · Mar 28, 2024
- Aldeyra Therapeutics Files 2023 Annual Report on Form 10-K — 10-K · Mar 7, 2024
- Aldeyra Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Aldeyra Therapeutics Files 8-K for Reg FD Disclosure — 8-K · Feb 13, 2024
- Aldeyra Therapeutics, INC. SC 13G Filing — SC 13G · Feb 13, 2024
- BlackRock Discloses 6.0% Passive Stake in Aldeyra Therapeutics — SC 13G · Jan 29, 2024
- Aldeyra Therapeutics Updates Corporate Contact Info in 8-K Filing — 8-K · Jan 4, 2024